Psoriasis and cardiovascular disease: Another contribution in the hierarchy of evidence

British Journal of Dermatology

Volumn 167, Issue 6, 2012, Pages 1198-1199

  Kimball, A B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE SEVERITY; HYPERTENSION; NOTE; OBESITY; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; T LYMPHOCYTE;

HUMANS; MYOCARDIAL INFARCTION; PSORIASIS; STROKE;

EID: 84870206220     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12089     Document Type: Note

References (6)

1. Henseler T, Christophers E,. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982-6.
2. Robinson D Jr, Hackett M, Wong J, et al. Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001-2002. Curr Med Res Opin 2006; 22: 989-1000.
3. Xu T, Zhang Y-H,. Association of psoriasis with stroke and myocardial infarction: meta-analysis of cohort studies. Br J Dermatol 2012; 167: 1345-50.
4. Bender AE, Bender DA, eds. Body surface area. In: A Dictionary of Food and Nutrition. New York: Oxford University Press, 1995.
5. Chen S, Crother TR, Arditi M,. Emerging role of IL-17 in atherosclerosis. J Innate Immun 2010; 2: 325-33.
6. Buzney EA, Kimball AB,. A critical assessment of composite and coprimary endpoints: a complex problem. J Am Acad Dermatol 2008; 59: 890-6.